Bristol-Myers Squibb Co
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Bristol-Myers Squibb Co in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Bristol-Myers Squibb Co.
Recent articles on PMLiVE featuring Bristol-Myers Squibb Co
Opdivo Qvantig can be administered in three to five minutes compared to 30 minutes for the drug’s IV form
The drug was approved by the US regulator last year to treat ROS1-positive NSCLC
Hepatocellular carcinoma accounts for 90% of all liver cancer cases and is often diagnosed at an advanced stage
The rare form of non-Hodgkin lymphoma accounts for around 3% of all NHL cases
UC accounts for approximately 90% of all bladder cancers, the ninth most common cancer globally
KRAS G12C occurs in approximately 14% of NSCLC, the most common form of lung cancer
With Merck and BMS first out of the gates, here comes the assault on the Inflation Reduction Act
Protein degrader drugs have been proposed as a way to address ‘undruggable’ targets
The investigational treatment regimen met its primary endpoint of overall survival
By Danny Buckland
Breyanzi demonstrated a statistically significant improvement in event-free survival compared to standard of care
Abecma is a CAR T cell therapy approved for pre-treated myeloma patients
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology